Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Stock

Tesla, Spirit Airlines and CVS Health rise premarket; Nvidia falls

admin by admin
November 18, 2024
in Stock
0
Tesla, Spirit Airlines and CVS Health rise premarket; Nvidia falls
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Investing.com — US stock futures traded in a mixed fashion Monday, with traders awaiting more corporate earnings as well as speeches from a number of Fed officials.

Here are some of the biggest premarket US stock movers today:

  • Tesla (NASDAQ:TSLA) stock surged 5.9% following reports from Bloomberg that the incoming Trump administration will establish a federal framework for fully self-driving vehicles and make it a top priority for the Department of Transportation.

  • Nvidia (NASDAQ:NVDA) stock fell 3.4% amid doubts over the strength of sales of its new Blackwell chips, ahead of the chipmaker’s quarterly earnings on Wednesday.

  • Spirit Airlines (NYSE:SAVE) stock rose 2.8% after the budget carrier filed for bankruptcy protection after years of mounting losses, stating that it has reached a prearranged deal with its bondholders to help it through the bankruptcy, which it expects to exit in the first quarter of next year.

  • Ford (NYSE:F) stock rose 0.3% despite the US auto safety regulator stating it had initiated a recall query into about 112,567 of the auto giant’s SUVs over an issue with seat belt retractors.

  • CVS Health (NYSE:CVS) stock rose 1.9% after the pharmacy chain said it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund’s chief executive Larry Robbins.

  • Super Micro Computer (NASDAQ:SMCI) stock rose over 10% as investors awaited a planned filing that would allow the server maker to avoid being delisted

  • Astera Labs (NASDAQ:ALAB) stock rose 3% after Citi initiated coverage of the semiconductor stock with a ‘buy’ rating, saying the shares provide artificial intelligence investors with a unique opportunity.

  • Syndax Pharmaceuticals (NASDAQ:SNDX) stock rose 6% after the FDA approved its Revuforj drug for the treatment of certain leukemia patients.

This post appeared first on investing.com

Previous Post

Brazil sees 3.3% GDP growth this year and 2.5% next year

Next Post

CVS adds four new board members in deal with Glenview Capital

admin

admin

Next Post
CVS adds four new board members in deal with Glenview Capital

CVS adds four new board members in deal with Glenview Capital

Trending News

Canada slaps $20B in retaliatory tariffs on US goods amid trade tensions

Canada slaps $20B in retaliatory tariffs on US goods amid trade tensions

March 13, 2025
Earnings call: Amazon reports strong Q3 2024 growth, AI and AWS surge

Earnings call: Amazon reports strong Q3 2024 growth, AI and AWS surge

November 3, 2024
Can Saudi Arabia’s $1.5T Neom sustain its spending spree?

Can Saudi Arabia’s $1.5T Neom sustain its spending spree?

November 25, 2024
Subscribe to Insightful Word


    Recent News

    ARB eyes recovery as Arbitrum taps agentic DeFi revolution with $1M grant

    ARB eyes recovery as Arbitrum taps agentic DeFi revolution with $1M grant

    June 5, 2025
    Ripple releases $2.18B in XRP, price dips 2%

    Ripple releases $2.18B in XRP, price dips 2%

    June 5, 2025
    Nintendo Switch 2 launch sees shortages as 2.2M vie for units in Japan

    Nintendo Switch 2 launch sees shortages as 2.2M vie for units in Japan

    June 5, 2025
    Why Bank of America sees 13% upside on Roblox (RBLX)

    Why Bank of America sees 13% upside on Roblox (RBLX)

    June 5, 2025

    Recent News

    ARB eyes recovery as Arbitrum taps agentic DeFi revolution with $1M grant

    ARB eyes recovery as Arbitrum taps agentic DeFi revolution with $1M grant

    June 5, 2025
    Ripple releases $2.18B in XRP, price dips 2%

    Ripple releases $2.18B in XRP, price dips 2%

    June 5, 2025

    Latest News

    • ARB eyes recovery as Arbitrum taps agentic DeFi revolution with $1M grant
    • Ripple releases $2.18B in XRP, price dips 2%
    • Nintendo Switch 2 launch sees shortages as 2.2M vie for units in Japan

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.